Use the Search Fields to Find Information
Page 77 of 382
Research Review: What we have learned about the endocannabinoid system in developmental psychopathology
Abstract Background The endocannabinoid (eCB) system, the primary target of cannabis, has gained significant attention as a potential novel therapeutic approach for treating a range
May 3, 2026
Research Letter: Unveiling the boundaries: Analysing advertising breaches in the promotion of medicinal cannabis in Australia
Please use this link to access this publication.
May 17, 2026
Research design concerns in a retrospective analysis of neurological disorders and cannabis abuse
Please use this link to access this publication.
February 22, 2026
Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
Abstract Background: Emerging evidence supports cannabidiol (CBD) as a promising therapeutic compound for various health conditions, despite its approval as a medication (product for medical
December 21, 2025
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
Severe childhood epilepsies are characterized by frequent seizures, neurodevelopmental delays and impaired quality of life. In these treatment-resistant epilepsies, families often seek alternative treatments. This
September 19, 2019
Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation
Abstract This narrative review explores the benefits and risks of cannabinoids in kidney health, particularly in individuals with pre-existing renal conditions. It discusses the roles
February 22, 2026
Relief of nocturnal neuropathic pain with the use of cannabis in a patient with Fabry disease
Abstract Neuropathic pain is one of the most invalidating symptoms in patients with Fabry disease (FD), affecting their quality of life, it is linked to small fiber
December 7, 2023
Relief in Gastrointestinal Symptoms with Medical Marijuana Over 1 Year
Abstract Introduction: Subjective improvement in gastrointestinal (GI) symptoms was assessed among patients using medical marijuana (MMJ). Methods: Participants completed surveys at 0 days, 30 days, 6 months, and
March 6, 2025
Release of delta-9-tetrahydrocannabinol from polyvinyl alcohol hydrogels and its safe interaction with human skin fibroblasts
Abstract This study aimed to design a THC-rich hydrogel to deliver cannabis derivatives topically. We developed hydrogels using polyvinyl alcohol (PVA) mixed with propylene glycol
September 5, 2024
Relative Risk of All-Cause Mortality Associated With Cannabis Use: A Systematic Review and Meta-Analysis of Cohort Studies
ABSTRACT Background and Aims Cannabis use has high prevalence and health burden. Although the effects of cannabis use have been studied in the literature, no
May 10, 2026
Page 77 of 382